CALEDONIAN NEUROSCIENCE LIMITED

💤Zombieactive

SC246461 · ltd · incorporated 2003-03-26

Investment thesis

Zombie company — trading but stalled; unlikely mover.

Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.

Why risky: No growth signal; thin margin for error on price.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Apr 2025

Net worth

£7.1k

book net assets

Opportunity

80/100

Exceptional

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Specialist medical practice activities

Sector: Human health & social work

Investor take

Pursue

Asset-holding vehicle with a 60-year-old founder — textbook succession opportunity.

Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 60). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (77/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

4 officers (2 active, 4 linked, 1 with DOB)

Ownership & PSC

2 active PSC(s) of 2 total, 2 with control declared

Director network

1 connected companies via shared directors

Filing history

51 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

80/100Exceptional

PassWatchWorth a lookStrongExceptional

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared

Positive net assets

Net assets £7,131

Net assets shrinking

Down £2,808 YoY

Cash YoY

-13%

Year on year

Key financials

2 years extracted from filed iXBRL accounts

Cash

£12k

↓ 13% YoY

Net Worth

£7k

↓ 28% YoY

Current Assets

£12k

↓ 20% YoY

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown

Metric	2025-04-30	2024-04-30
Total assets	£7.1k	£9.9k
Current assets	£12.1k	£15.2k
Cash	£12.1k	£14.0k
Debtors	—	£1.2k
Net assets	£7.1k	£9.9k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filing

• 1 confirmation-statement

Last 180 days

filings

• 1 confirmation-statement
• 1 accounts

Counts from Companies House filing history.

Corporate timeline (22 events)Click to expand

2025-12-10
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-01-06
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-01-22
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-01-25
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-01-13
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-02-02
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2019-12-11
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2019-01-09
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2017-12-17
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2016-11-23
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2016-04-11
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2015-12-16
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2015-03-26
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2014-10-16
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2014-04-23
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2003-03-26
🏢
Company incorporated
As CALEDONIAN NEUROSCIENCE LIMITED
2003-03-26
➕
ZUBERI, Dawn appointed
secretary
2003-03-26
➕
ZUBERI, Sameer Mustafa, Professor appointed
director
2003-03-26
➕
WATERLOW SECRETARIES LIMITED appointed
corporate-nominee-secretary
2003-03-26
➖
WATERLOW SECRETARIES LIMITED resigned
corporate-nominee-secretary
2003-03-26
➕
WATERLOW NOMINEES LIMITED appointed
corporate-nominee-director
2003-03-26
➖
WATERLOW NOMINEES LIMITED resigned
corporate-nominee-director

Owner dependency

93/100

Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS

+Sole director: Only one active director — all governance concentrated on one person.
+Long-tenure founder: Senior director has been in place 23 years — deep operational knowledge concentrated in one person.
+Senior director age: Director aged approximately 60 — approaching natural succession window.

Succession & seller-readiness

85/100

Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS

secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
primary20+ year tenure: Director in role 23 years. Very long tenure is a classic succession signal.
secondaryStable-but-static management: Company is 23 years old and no new directors in the last 3 years — succession not yet being planned internally.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners

Name	Shares	Voting rights	Nature of control	Notified
Professor Sameer Mustafa Zuberi Individual · British · DOB 02/1966 · age 60	25–50%	—	sig. influence25-50% shares · significant influence · firm interest	06/04/2016
Mrs Dawn Zuberi Individual · British · DOB 05/1965 · age 61	25–50%	—	25-50% shares	06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · G postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
B SIRCAR AND SIRCAR LIMITED→ SC484487 · est 2014 · no financials extracted	—	—	—	—	11y	—	—
BIRCHFIELD DENTAL CARE LIMITED→ SC666652 · est 2020 · no financials extracted	—	—	—	—	5y	—	—
BLAIR EDWARD LIMITED→ SC314148 · est 2007 · no financials extracted	—	—	—	—	19y	—	—
BLOSSOM 24 LTD→ SC797799 · est 2024 · no financials extracted	—	—	—	—	2y	—	—
CALEDONIAN OH SERVICES LTD→ SC808187 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
CAMCARE SUPPORT SERVICES LTD→ SC828805 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
CAMPBELL SKIN HEALTH LTD→ SC825111 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
CARE COMPASSIONATELY LTD→ SC825748 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
CARE HOMES (SCOTLAND) LTD.→ SC257954 · est 2003 · no financials extracted	—	—	—	—	22y	—	—
CARE NO1 LTD→ SC567064 · est 2017 · no financials extracted	—	—	—	—	8y	—	—
CARE PHYSIO SECRETS LTD→ SC830384 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
CARE RESPONSE DIRECT LIMITED→ SC845634 · est 2025 · no financials extracted	—	—	—	—	1y	—	—

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2003-03-26

Jurisdictionscotland

Primary SIC86220 — Specialist medical practice activities

Registered office

21 Ormonde Drive

Netherlee

Glasgow

G44 3SR

Filing status

Accounts

Next due: 2027-01-31

Last made up to: 2025-04-30

Confirmation statement

Next due: 2027-03-14

Last: 2026-02-28

Officers (2 active · 2 resigned)

ZUBERI, Dawn→

secretary · appointed 2003-03-26

View their other companies + combined net worth →

Active

ZUBERI, Sameer Mustafa, Professor→

director · ~60y · appointed 2003-03-26

View their other companies + combined net worth →

Active

WATERLOW SECRETARIES LIMITED→

corporate-nominee-secretary · appointed 2003-03-26 · resigned 2003-03-26

Resigned

WATERLOW NOMINEES LIMITED→

corporate-nominee-director · appointed 2003-03-26 · resigned 2003-03-26

Resigned

Click a director name to see their full track record across all companies.